References
- Bonilla Guerrero, R. and Roberts, L. R. (2005) The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J. Hepatol. 42, 760-777. https://doi.org/10.1016/j.jhep.2005.02.005
- Matsubara, K. and Tokino, T. (1990) Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol. Biol. Med. 7, 243-260.
- Tsai, W. L. and Chung, R. T. (2010) Viral hepatocarcinogenesis. Oncogene 29, 2309-2324. https://doi.org/10.1038/onc.2010.36
- Wollersheim, M., Debelka, U. and Hofschneider, P. H. (1988) A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 3, 545-552.
- Brechot, C. (2004) Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127, S56-61. https://doi.org/10.1053/j.gastro.2004.09.016
- Gozuacik, D., Murakami, Y., Saigo, K., Chami, M., Mugnier, C., Lagorce, D., Okanoue, T., Urashima, T., Brechot, C. and Paterlini-Brechot, P. (2001) Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging. Oncogene 20, 6233-6240. https://doi.org/10.1038/sj.onc.1204835
- Minami, M., Daimon, Y., Mori, K., Takashima, H., Nakajima, T., Itoh, Y. and Okanoue, T. (2005) Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Oncogene 24, 4340-4348. https://doi.org/10.1038/sj.onc.1208628
- Horikawa, I. and Barrett, J. C. (2001) cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome. J. Natl. Cancer. Inst. 93, 1171-1173. https://doi.org/10.1093/jnci/93.15.1171
- Feitelson, M. A. and Lee, J. (2007) Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer. Lett. 252, 157-170. https://doi.org/10.1016/j.canlet.2006.11.010
- Murakami, Y., Yasuda, T., Saigo, K., Urashima, T., Toyoda, H., Okanoue, T. and Shimotohno, K. (2006) Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25, 2537-2545. https://doi.org/10.1038/sj.onc.1209283
- Wang, J., Zindy, F., Chenivesse, X., Lamas, E., Henglein, B. and Brechot, C. (1992) Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene 7, 1653-1656.
- Paterlini-Brechot, P., Saigo, K., Murakami, Y., Chami, M., Gozuacik, D., Mugnier, C., Lagorce, D. and Brechot, C. (2003) Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 22, 3911-3916. https://doi.org/10.1038/sj.onc.1206492
- Murakami, Y., Saigo, K., Takashima, H., Minami, M., Okanoue, T., Brechot, C. and Paterlini-Brechot, P. (2005) Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54, 1162-1168. https://doi.org/10.1136/gut.2004.054452
- Glover, T. W. (2006) Common fragile sites. Cancer. Lett. 232, 4-12. https://doi.org/10.1016/j.canlet.2005.08.032
- Ahn, S. H., Yuen, L., Han, K. H., Littlejohn, M., Chang, H. Y., Damerow, H., Ayres, A., Heo, J., Locarnini, S. and Revill, P. A. (2010) Molecular and clinical characteristics of hepatitis B virus in Korea. J. Med. Virol. 82, 1126-1134. https://doi.org/10.1002/jmv.21844
- Norder, H., Courouce, A. M., Coursaget, P., Echevarria, J. M., Lee, S. D., Mushahwar, I. K., Robertson, B. H., Locarnini, S. and Magnius, L. O. (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47, 289-309. https://doi.org/10.1159/000080872
- Hatada, I., Tokino, T., Ochiya, T. and Matsubara, K. (1988) Co-amplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma. Oncogene 3, 537-540.
- Tokino, T. and Matsubara, K. (1991) Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma. J. Virol. 65, 6761-6764.
- Tamori, A., Nishiguchi, S., Shiomi, S., Hayashi, T., Kobayashi, S., Habu, D., Takeda, T., Seki, S., Hirohashi, K., Tanaka, H. and Kubo, S. (2005) Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus. Am. J. Gastroenterol. 100, 1748-1753. https://doi.org/10.1111/j.1572-0241.2005.41914.x
- Luo, M. L., Shen, X. M., Zhang, Y., Wei, F., Xu, X., Cai, Y., Zhang, X., Sun, Y. T., Zhan, Q. M., Wu, M. and Wang, M. R. (2006) Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer. Res. 66, 11690-11699. https://doi.org/10.1158/0008-5472.CAN-06-1484
- Kusano, N., Shiraishi, K., Kubo, K., Oga, A., Okita, K. and Sasaki, K. (1999) Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology 29, 1858-1862. https://doi.org/10.1002/hep.510290636
- Chen, C. F., Hsu, E. C., Lin, K. T., Tu, P. H., Chang, H. W., Lin, C. H., Chen, Y. J., Gu, D. L., Wu, J. Y., Chen, Y. T., Hsu, M. T. and Jou, Y. S. (2010) Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma. Hepatology 52, 1690-1701. https://doi.org/10.1002/hep.23847
- Sawey, E. T., Chanrion, M., Cai, C., Wu, G., Zhang, J., Zender, L., Zhao, A., Busuttil, R. W., Yee, H., Stein, L., French, D. M., Finn, R. S., Lowe, S. W. and Powers, S. (2011) Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer. Cell. 19, 347-358. https://doi.org/10.1016/j.ccr.2011.01.040
- Ornitz, D. M. and Itoh, N. (2001) Fibroblast growth factors. Genome. Biol. 2, REVIEWS3005.
- Nicholes, K., Guillet, S., Tomlinson, E., Hillan, K., Wright, B., Frantz, G. D., Pham, T. A., Dillard-Telm, L., Tsai, S. P., Stephan, J. P., Stinson, J., Stewart, T. and French, D. M. (2002) A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am. J. Pathol. 160, 2295-2307. https://doi.org/10.1016/S0002-9440(10)61177-7
- Pai, R., Dunlap, D., Qing, J., Mohtashemi, I., Hotzel, K. and French, D. M. (2008) Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling. Cancer. Res. 68, 5086-5095. https://doi.org/10.1158/0008-5472.CAN-07-2325
- Miura, S., Mitsuhashi, N., Shimizu, H., Kimura, F., Yoshidome, H., Otsuka, M., Kato, A., Shida, T., Okamura, D. and Miyazaki, M. (2012) Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma. BMC. cancer. 12, 56. https://doi.org/10.1186/1471-2407-12-56
- Buschges, R., Weber, R. G., Actor, B., Lichter, P., Collins, V. P. and Reifenberger, G. (1999) Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas. Brain. Pathol. 9, 435-442; discussion 432-433. https://doi.org/10.1111/j.1750-3639.1999.tb00532.x
- Wessendorf, S., Schwaenen, C., Kohlhammer, H., Kienle, D., Wrobel, G., Barth, T. F., Nessling, M., Moller, P., Dohner, H., Lichter, P. and Bentz, M. (2003) Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization. Oncogene 22, 1425-1429. https://doi.org/10.1038/sj.onc.1206297
- Huang, X., Gollin, S. M., Raja, S. and Godfrey, T. E. (2002) High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc. Natl. Acad. Sci. USA. 99, 11369-11374. https://doi.org/10.1073/pnas.172285799
- Nishida, N., Fukuda, Y., Komeda, T., Kita, R., Sando, T., Furukawa, M., Amenomori, M., Shibagaki, I., Nakao, K., Ikenaga, M. and Ishizaki, K. (1994) Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer. Res. 54, 3107-3110.
- Shamay, M., Agami, R. and Shaul, Y. (2001) HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer. Oncogene 20, 6811-6819. https://doi.org/10.1038/sj.onc.1204879
- Park, J. G., Lee, J. H., Kang, M. S., Park, K. J., Jeon, Y. M., Lee, H. J., Kwon, H. S., Park, H. S., Yeo, K. S., Lee, K. U., Kim, S. T., Chung, J. K., Hwang, Y. J., Lee, H. S., Kim, C. Y., Lee, Y. I., Chen, T. R., Hay, R. J., Song, S. Y., Kim, W. H., Kim, C. W. and Kim, Y. I. (1995) Characterization of cell lines established from human hepatocellular carcinoma. Int. J. Cancer. 62, 276-282. https://doi.org/10.1002/ijc.2910620308
- Lee, J. H., Ku, J. L., Park, Y. J., Lee, K. U., Kim, W. H. and Park, J. G. (1999) Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA. World. J. Gastroenterol. 5, 289-295.
- Asakawa, S., Abe, I., Kudoh, Y., Kishi, N., Wang, Y., Kubota, R., Kudoh, J., Kawasaki, K., Minoshima, S. and Shimizu, N. (1997) Human BAC library: construction and rapid screening. Gene 191, 69-79. https://doi.org/10.1016/S0378-1119(97)00044-9
- Schmittgen, T. D. and Livak, K. J. (2008) Analyzing real- time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108. https://doi.org/10.1038/nprot.2008.73
Cited by
- How did hepatitis B virus effect the host genome in the last decade? vol.6, pp.12, 2014, https://doi.org/10.4254/wjh.v6.i12.851